Cardiac growth factors in human hypertrophy: Relations with myocardial contractility and wall stress

Circulation Research

Volumn 85, Issue 1, 1999, Pages 57-67

  Serneri, Gian Gastone Neri ^a   Modesti, Pietro Amedeo ^b   Boddi, Maria ^b   Cecioni, Ilaria ^b   Paniccia, Rita ^b   Coppo, Mirella ^b   Galanti, Giorgio ^b   Simonetti, Ignazio ^b   Vanni, Simone ^b   Papa, Letizia ^b   Bandinelli, Brunella ^b   Migliorini, Angela ^b   Modesti, Alessandra ^b   Maccherini, Massimo ^b   Sani, Guido ^b   Toscano, Michele ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b NONE

Author keywords

Angiotensin II; Aortic valve disease; Endothelin 1; Insulin like growth factor I; Myocardial hypertrophy

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; ENDOTHELIN 1; GROWTH FACTOR; MESSENGER RNA; SOMATOMEDIN C;

ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART HYPERTROPHY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE FUNCTION; HUMAN; MUSCLE CELL; PRIORITY JOURNAL;

EID: 0033538642     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.1.57     Document Type: Article

References (50)

1. Morgan HE, Baker KM. Cardiac hypertrophy: mechanical, neural and endocrine dependence. Circulation. 1991;83:13-25.
2. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 1993;55:55-75.
3. Cooper G IV. Basic determinants of myocardial hypertrophy: a review of molecular mechanisms. Annu Rev Med. 1997;48:13-23.
4. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 1997;59:551-571.
5. Hefti MA, Harder BA. Eppenberger HM. Schaub MC. Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1997;29: 2873-2892.
6. Kennedy JW, Doces J, Stewart DK. Left ventricular function before and following aortic valve replacement. Circulation. 1977;56:944-950.
7. Schwarz F, Flameng W, Schaper J, Langebartels F, Sesto M, Hehrlein F, Schlepper M. Myocardial structure and function in patients with aortic valve disease and their relation to postoperative results. Am J Cardiol. 1978;41:661-669.
8. Krayenbuehl H P, Hess OM, Monrad SE, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation. 1989;79: 744-755.
9. Li RK, Li G, Mickle DAG, Weisel RD, Merante F, Luss H, Rao V, Christakis GT, Williams WG. Overexpression of transforming growth factor-β1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation. 1997;96:874-881.
10. World Medical Association. Human experimentation: code of ethics of the World Medical Association. Br Med J. 1964;ii:177-180.
11. Wilson JR, Reichek N, Hirshfeld J. Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation. Am J Med. 1980;68:664-674.
12. Reichek N, Wilson J, Sutton MJ, Plappert TA, Goldberg S, Hirshfeld JW. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 1982;65: 99-108.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
14. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man; validation of the method. Circulation. 1977;55: 613-618.
15. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J, Feinleib M, Castelli WP. The spectrum of left ventricular in a general population sample: the Framingham Study. Circulation. 1987;75(suppl I):I-26-I-33.
16. Grossmann W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56-64.
17. Neri Serneri GG, Boddi M, Arata L, Rostagno C, Dabizzi P, Coppo M, Bini M, Lazzerini S, Dagianti A, Gensini GF. Silent ischemia in unstable angina is related to an altered cardiac norepinephrine handling. Circulation. 1993;87:1928-1937.
18. Neri Serneri GG, Boddi M, Coppo M, Chechi T, Zarone N, Poggesi L, Margheri M, Simonetti I. Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation. 1996;94: 1886-1896.
19. Neri Serneri GG, Modesti PA, Cecioni I, Biagini D, Migliorini A, Costoli A, Colella A, Naldoni A, Paoletti P. Plasma endothelin and renal endothelin are two distinct systems involved in volume homeostasis. Am J Physiol. 1995;268:H1829-H1837.
20. Admiraal PJJ, Danser AHJ, Jong S, Pieterman H, Derkx FHM, Schalekamp M. Regional angiotensin II in essential hypertension and renal artery stenosis. Hypertension. 1993;21:173-184.
21. Danser AH, Koning MM, Admiraal PJ, Sassen LM, Derkx FH, Verdouw PD, Schalekamp MA. Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol. 1992;263:H429-H437.
22. Boddi M, Poggesi L, Coppo M, Zarone N, Sacchi S, Chechi T, Neri Serneri GG. Human vascular renin angiotensin system and its functional changes in relation to different sodium intakes. Hypertension. 1998;31: 836-842.
23. Gorlin R, Storaasli JP. Transcoronary circulation time: a new method for evaluating the coronary vascular system. Circulation. 1956;14:943-944.
24. Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton CJ, Lange M, Uhl E, Weindl A, Stalla GK. Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. J Clin Invest. 1995;96:2017-2025.
25. Paul M, Wagner J, Dzau VJ. Gene expression of the renin-angiotensin system in human tissues. J Clin Invest. 1993;91:2058-2064.
26. Modesti PA, Cecioni I, Migliorini A, Naldoni A, Costoli A, Vanni S, Neri Serneri GG. Increased renal formation is associated with sodium retention and increased free water clearance. Am J Physiol. 1998;275: H1070-H1077.
27. Calderone A, Takahashi N, Izzo NJ Jr, Thaik CM, Colucci WS. Pressureand volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 1995;92:2385-2390.
28. Yamazaki T, Komuro I, Yazaki Y. Molecular mechanism of cardiac cellular hypertrophy by mechanical stress. J Mol Cell Cardiol. 1995;27: 133-140.
29. Lee YA, Liang CS, Lee MA, Lindpaintner K. Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. Proc Natl Acad Sci U S A. 1996;93:11035-11040.
30. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Schichiri M, Koike A, Nogami A, Marumo F. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation. 1993;87:1715-1721.
31. Cittadini A, Stromer H, Katz SE, Ross C, Moses AC, Morgan JP, Douglas PS. Differential cardiac effects of growth hormone and insulin-like growth factor-I in the rat: a combined in vivo and in vitro evaluation. Circulation. 1996;93:800-809.
32. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr. Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995;95:619-627.
33. Redaelli G, Malhotra A, Li B, Li P, Sonnenblick EH, Hofmann PA, Anversa P. Effects of constitutive overexpression of insulin-like growth factor-I on the mechanical characteristics and molecular properties of ventricular myocytes. Circ Res. 1998;82:594-603.
34. Hess OM, Ritter M, Schneider J, Grimm J, Turina M, Krayenbuehl HP. Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation. 1984;69:855-865.
35. Ito H. Endothelins and cardiac hypertrophy. Life Sci. 1997;6:585-593.
36. Feldman AM, Weinberg EO, Rai PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192.
37. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac genes expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix components. Circ Res. 1994;75:23-32.
38. Arai M, Suzuki T, Nagai R. Sarcoplasmic reticulum genes are up-regulated in mild cardiac hypertrophy but down-regulated in severe cardiac hypertrophy induced by pressure overload. J Mol Cell Cardiol. 1996;28:1583-1590.
39. Decker ML, Janes DM, Barclay MM, Harger L, Decker RS. Regulation of adult cardiocyte growth: effects of active and passive mechanical loading. Am J Physiol. 1997;272:H2002-H2918.
40. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
41. Leri A, Claudio PP, Li Q, Wang X, Reiss K, Wang S, Malhotra A, Kajstura J, Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
42. Horban A, Kolbeck-Ruhmkorff C, Zimmer HG. Correlation between function and proto-oncogene expression in isolated working rat hearts under various overload conditions. J Mol Cell Cardiol. 1997;29: 2903-2914.
43. Shunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin-converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest. 1990;86: 1913-1920.
44. Koide M, Carabello BA, Conrad CC, Buckley JM, DeFreyte G, Barnes M, Tomanek RJ, Wei CC, Dell'Italia LJ, Cooper G 4th, Zile MR. Hypertrophic response to hemodynamic overload: role of load vs reninangiotensin system activation. Am J Physiol. 1999;276:H350-H358.
45. Yamazaki T, Yazaki Y. Is there major involvement of the renin angiotensin system in cardiac hypertrophy? Circ Res. 1997;81:639-642.
46. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo Ang II generation. Circulation. 1997;96:4045-4082.
47. Shunkert H, Jackson B, Tang SS, Schoen FJ, Smits JF, Apstein CS, Lorell BH. Distribution and functional significance of cardiac angiotensin-converting enzyme in hypertrophied rat hearts. Circulation. 1993;87: 1328-1339.
48. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 1997;29:859-870.
49. Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. Circulation. 1997;96: 4002-4010.
50. Cohn JN. Overview of the treatment of heart failure. Am J Cardiol. 1997;80:2L-6L.